ACER THERAPEUTICS INC.
CIK 0001069308
Revenue (TTM)
$1.26M
Q3 Nov 2023
Net Income (TTM)
−$44.11M
−70.7% YoY
Q3 Nov 2023
EPS Diluted (TTM)
−$2.01
−53.7% YoY
Q3 Nov 2023
Gross Margin
—
Q3 Nov 2023
Operating Margin
-2,174.7%
Q3 Nov 2023
Net Margin
-3,500.8%
Q3 Nov 2023
Free Cash Flow (TTM)
−$14.22M
Q3 Nov 2023
Cash
$594.66K
Q3 Nov 2023
Total Debt
$418.7K
Q3 Nov 2023
Shares Outstanding
24.46M sh
Q3 Nov 2023
Revenue & Net Income
EPS (Diluted)
Margins
Cash Flow
Revenue Growth (YoY)
No data available for this metric.